Cargando…

Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development

Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus Disease 2019 (COVID-19) infections are the three epidemiological diseases caused by the Coronaviridae family. Perceiving the immune responses in these infections and the escape of viruses could help us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ansariniya, Hossein, Seifati, Seyed Mohammad, Zaker, Erfan, Zare, Fateme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841448/ https://www.ncbi.nlm.nih.gov/pubmed/33564683 http://dx.doi.org/10.1155/2021/8870425

Ejemplares similares

Modulatory Effect of Probiotics on Proinflammatory Cytokine Levels in Acrylamide-Treated Rats
por: Seifati, Seyed Mohammad, et al.
Publicado: (2021)

Possible Role of Leukemia Inhibitory Factor and Inflammatory Cytokines in The Recurrent Spontaneous Abortion: A Case-Control Study
por: Miresmaeili, Seyed Mohsen, et al.
Publicado: (2023)

Preimplantation Factor (PIF): a peptide with various functions
por: Zare, Fateme, et al.
Publicado: (2020)

Impact of Vitamin C on Gene Expression Profile of Inflammatory and Anti-Inflammatory Cytokines in the Male Partners of Couples with Recurrent Pregnancy Loss
por: Fesahat, Farzaneh, et al.
Publicado: (2022)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Coronavirus vaccine development: from SARS and MERS to COVID-19
por: Li, Yen-Der, et al.
Publicado: (2020)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
por: Dai, Lianpan, et al.
Publicado: (2020)

Immune Profiling of COVID-19 in Correlation with SARS and MERS
por: Khalil, Bariaa A., et al.
Publicado: (2022)

A comparison of COVID-19, SARS and MERS
por: Hu, Tingting, et al.
Publicado: (2020)

COVID-19, SARS and MERS: A neurological perspective
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2020)

Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
por: Oves, Mohammad, et al.
Publicado: (2020)

Levels of Transforming Growth Factor-Beta After Immunization of Mice With in vivo prepared Toxoplasma gondii Excretory/Secretory Proteins
por: Abdollahi, Seyed Hossein, et al.
Publicado: (2015)

Is MERS another SARS?
por: Drosten, Christian
Publicado: (2013)

Association of GSTP1, GSTT1 and GSTM1 Gene Variants with Coronary Artery Disease in Iranian Population: A Case–Control Study
por: Pourkeramati, Alemeh, et al.
Publicado: (2020)

The effect of the anti-leukemia inhibitory factor on the immune system in the Balb/c mice bearing breast cancer induced with 4T1 cells
por: Yavari, Abolfazl, et al.
Publicado: (2023)

Acute Myocarditis Related to COVID-19: Comparison to SARS and MERS
por: Chasouraki, Angeliki M., et al.
Publicado: (2020)

Susceptibility to SARS, MERS, and COVID-19 from animal health perspective
por: Gautam, Aasish, et al.
Publicado: (2020)

Design and application of 60mer oligonucleotide microarray in SARS coronavirus detection
por: Shi, Rong, et al.
Publicado: (2003)

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
por: Ma, Cuiqing, et al.
Publicado: (2014)

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
por: Ganesh, Balasubramanian, et al.
Publicado: (2021)

A Computational Vaccine Designing Approach for MERS-CoV Infections
por: Ibrahim, Hiba Siddig, et al.
Publicado: (2020)

From SARS to MERS and Ebola
por: Yuen, Kwok Yung
Publicado: (2015)

Relationship between MspI polymorphism of CYP1A1 gene and the risk of endometriosis in an Iranian population: A case-control study
por: Babaki, Azam, et al.
Publicado: (2018)

Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine
por: O’Donnell, Jake S., et al.
Publicado: (2022)

Expression of TRPV1 as A Heat Sensitive Voltage-Dependent Ion Channel and Oxidative Stress in Sperm Samples of Infertile Men with Varicocele: A Case-Control Study
por: Salahshouri, Sahar, et al.
Publicado: (2022)

MERS-CoV vaccine candidates in development: The current landscape
por: Modjarrad, Kayvon
Publicado: (2016)

Calling for rapid development of a safe and effective MERS vaccine
por: Hotez, Peter J., et al.
Publicado: (2014)

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
por: Weskamm, Leonie M., et al.
Publicado: (2022)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
por: Du, Lanying, et al.
Publicado: (2016)

Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C
por: Dhaliwal, Manpreet, et al.
Publicado: (2022)

Nanobiosensors as new diagnostic tools for SARS, MERS and COVID-19: from past to perspectives
por: Antiochia, Riccarda
Publicado: (2020)

Animal models for SARS and MERS coronaviruses
por: Gretebeck, Lisa M, et al.
Publicado: (2015)

Influenza, Measles, SARS, MERS, and Smallpox
por: Chertow, Daniel S., et al.
Publicado: (2020)

From SARS to MERS: evidence and speculation
por: Gao, Hainv, et al.
Publicado: (2016)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu, Tong, et al.
Publicado: (2021)

Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S
por: Zheng, Jian, et al.
Publicado: (2023)

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

Intra-platform comparison of 25-mer and 60-mer oligonucleotide Nimblegen DNA microarrays
por: Fenart, Stephane, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kiemrg0fregn8v3ps7lgjf6bi6